Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Stanford Health Care

Genomic Analysis of Salivary Gland Cancer and Treatment of Salivary Gland Cancers.

Genomic Analysis of Salivary Gland Cancer and Treatment of Salivary Gland Cancers. Surgical pathology clinics Palsgrove, D., Allahabadi, S., Khan, S. A. 2021; 14 (1): 151–63

Abstract

Salivary gland cancer is a heterogenous group of tumors that presents challenges with both diagnosis and therapy. Recent advances in the classification of salivary gland cancers have led to distinct histologic and genomic criteria that successfully differentiate between cancers with similar clinical behavior and appearance. Genomic abnormalities have led to the emergence of targeted therapies being used in their therapy with drastic improvements in outcomes as well as reductions in treatment-related toxicity. Dramatic results seen with molecular targets, such as HER2, TRK, and others, indicate that this approach has the potential to yield even better treatments for the future.

View details for DOI 10.1016/j.path.2020.10.001

View details for PubMedID 33526219